comparemela.com

Latest Breaking News On - Diagnostics united - Page 1 : comparemela.com

Global Liver Cancer Diagnostics Market to Reach $22 Billion

Global Liver Cancer Diagnostics Market to Reach $43 6

$30 3 Million Worldwide Liver Cancer Diagnostics Industry to 2027 - Impact of COVID-19 on the Market

Share this article Share this article ResearchAndMarkets.com s offering. Amid the COVID-19 crisis, the global market for Liver Cancer Diagnostics estimated at US$30.3 Million in the year 2020, is projected to reach a revised size of US$43.6 Million by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Imaging, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$14 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Tests segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

Insights on the Liver Cancer Diagnostics Global Market to 2027 - Featuring Hologic, Illumina & Koninklijke Philips Among Others

Insights on the Liver Cancer Diagnostics Global Market to 2027 - Featuring Hologic, Illumina & Koninklijke Philips Among Others
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Global Liver Cancer Diagnostics Industry (2020 to 2027) - Key Market Trends and Drivers

Press release content from Business Wire. The AP news staff was not involved in its creation. Global Liver Cancer Diagnostics Industry (2020 to 2027) - Key Market Trends and Drivers - ResearchAndMarkets.com April 15, 2021 GMT DUBLIN (BUSINESS WIRE) Apr 15, 2021 Amid the COVID-19 crisis, the global market for Liver Cancer Diagnostics estimated at US$30.3 Million in the year 2020, is projected to reach a revised size of US$43.6 Million by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. ADVERTISEMENT Imaging, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$14 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Tests segment is readjusted to a revised 5.4% CAGR for the next 7-year period.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.